FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114460293> ?p ?o ?g. }

• W3114460293 abstract "Abstract Background Reports on the effects of renin–angiotensin–aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19) have been conflicting. We performed this meta-analysis to find conclusive evidence. Methods We searched published articles through PubMed, EMBASE and medRxiv from 5 January 2020 to 3 August 2020. Studies that reported clinical outcomes of patients with COVID-19, stratified by the class of antihypertensives, were included. Random and fixed-effects models were used to estimate pooled odds ratio (OR). Results A total 36 studies involving 30,795 patients with COVID-19 were included. The overall risk of poor patient outcomes (severe COVID-19 or death) was lower in patients taking RAAS inhibitors (OR = 0.79, 95% CI: [0.67, 0.95]) compared with those receiving non-RAAS inhibitor antihypertensives. However, further sub-meta-analysis showed that specific RAAS inhibitors did not show a reduction of poor COVID-19 outcomes when compared with any class of antihypertensive except beta-blockers (BBs). For example, compared to calcium channel blockers (CCBs), neither angiotensin-I-converting enzyme inhibitors (ACEIs) (OR = 0.91, 95% CI: [0.67, 1.23]) nor angiotensin-II receptor blockers (ARBs) (OR = 0.90, 95% CI: [0.62, 1.33]) showed a reduction of poor COVID-19 outcomes. When compared with BBs, however, both ACEIs (OR = 0.85, 95% CI: [0.73, 0.99) and ARBs (OR = 0.72, 95% CI: [0.55, 0.94]) showed an apparent decrease in poor COVID-19 outcomes. Conclusions RAAS inhibitors did not increase the risk of mortality or severity of COVID-19. Differences in COVID-19 clinical outcomes between different class of antihypertensive drugs were likely due to the underlying comorbidities for which the antihypertensive drugs were prescribed, although adverse effects of drugs such as BBs could not be excluded." @default.
• W3114460293 created "2021-01-05" @default.
• W3114460293 creator A5015800232 @default.
• W3114460293 creator A5052821508 @default.
• W3114460293 creator A5070855514 @default.
• W3114460293 creator A5073984194 @default.
• W3114460293 creator A5074193099 @default.
• W3114460293 date "2021-06-05" @default.
• W3114460293 modified "2023-10-17" @default.
• W3114460293 title "Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes" @default.
• W3114460293 cites W2028521865 @default.
• W3114460293 cites W2107328434 @default.
• W3114460293 cites W2558084536 @default.
• W3114460293 cites W3004465995 @default.
• W3114460293 cites W3009912996 @default.
• W3114460293 cites W3010596635 @default.
• W3114460293 cites W3012725239 @default.
• W3114460293 cites W3012818885 @default.
• W3114460293 cites W3013231340 @default.
• W3114460293 cites W3013564424 @default.
• W3114460293 cites W3013871850 @default.
• W3114460293 cites W3015407900 @default.
• W3114460293 cites W3015761555 @default.
• W3114460293 cites W3016535995 @default.
• W3114460293 cites W3017545174 @default.
• W3114460293 cites W3021241497 @default.
• W3114460293 cites W3021366174 @default.
• W3114460293 cites W3022580747 @default.
• W3114460293 cites W3023529892 @default.
• W3114460293 cites W3023640683 @default.
• W3114460293 cites W3023670326 @default.
• W3114460293 cites W3023702343 @default.
• W3114460293 cites W3023751598 @default.
• W3114460293 cites W3025304547 @default.
• W3114460293 cites W3028575869 @default.
• W3114460293 cites W3029048120 @default.
• W3114460293 cites W3030579723 @default.
• W3114460293 cites W3031240096 @default.
• W3114460293 cites W3032939692 @default.
• W3114460293 cites W3033263367 @default.
• W3114460293 cites W3033315848 @default.
• W3114460293 cites W3034110780 @default.
• W3114460293 cites W3034567463 @default.
• W3114460293 cites W3035752400 @default.
• W3114460293 cites W3035790792 @default.
• W3114460293 cites W3038414115 @default.
• W3114460293 cites W3038451890 @default.
• W3114460293 cites W3039509428 @default.
• W3114460293 cites W3042235182 @default.
• W3114460293 cites W3043261154 @default.
• W3114460293 cites W3043851305 @default.
• W3114460293 cites W3083980445 @default.
• W3114460293 cites W3165765895 @default.
• W3114460293 cites W4245391004 @default.
• W3114460293 doi "https://doi.org/10.1186/s12879-021-06088-6" @default.
• W3114460293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8178664" @default.
• W3114460293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34090358" @default.
• W3114460293 hasPublicationYear "2021" @default.
• W3114460293 type Work @default.
• W3114460293 sameAs 3114460293 @default.
• W3114460293 citedByCount "8" @default.
• W3114460293 countsByYear W31144602932021 @default.
• W3114460293 countsByYear W31144602932022 @default.
• W3114460293 countsByYear W31144602932023 @default.
• W3114460293 crossrefType "journal-article" @default.
• W3114460293 hasAuthorship W3114460293A5015800232 @default.
• W3114460293 hasAuthorship W3114460293A5052821508 @default.
• W3114460293 hasAuthorship W3114460293A5070855514 @default.
• W3114460293 hasAuthorship W3114460293A5073984194 @default.
• W3114460293 hasAuthorship W3114460293A5074193099 @default.
• W3114460293 hasBestOaLocation W31144602931 @default.
• W3114460293 hasConcept C126322002 @default.
• W3114460293 hasConcept C156957248 @default.
• W3114460293 hasConcept C198710026 @default.
• W3114460293 hasConcept C2778176773 @default.
• W3114460293 hasConcept C2779134260 @default.
• W3114460293 hasConcept C2780035454 @default.
• W3114460293 hasConcept C2910553456 @default.
• W3114460293 hasConcept C3008058167 @default.
• W3114460293 hasConcept C524204448 @default.
• W3114460293 hasConcept C71924100 @default.
• W3114460293 hasConcept C84393581 @default.
• W3114460293 hasConcept C95190672 @default.
• W3114460293 hasConcept C98274493 @default.
• W3114460293 hasConceptScore W3114460293C126322002 @default.
• W3114460293 hasConceptScore W3114460293C156957248 @default.
• W3114460293 hasConceptScore W3114460293C198710026 @default.
• W3114460293 hasConceptScore W3114460293C2778176773 @default.
• W3114460293 hasConceptScore W3114460293C2779134260 @default.
• W3114460293 hasConceptScore W3114460293C2780035454 @default.
• W3114460293 hasConceptScore W3114460293C2910553456 @default.
• W3114460293 hasConceptScore W3114460293C3008058167 @default.
• W3114460293 hasConceptScore W3114460293C524204448 @default.
• W3114460293 hasConceptScore W3114460293C71924100 @default.
• W3114460293 hasConceptScore W3114460293C84393581 @default.
• W3114460293 hasConceptScore W3114460293C95190672 @default.
• W3114460293 hasConceptScore W3114460293C98274493 @default.
• W3114460293 hasIssue "1" @default.
• W3114460293 hasLocation W31144602931 @default.
• W3114460293 hasLocation W31144602932 @default.

• next